REL Share Price Performance
UK£33.51
-2.66 (-7.35%)
24.2% undervalued intrinsic discount
UK£44.18
Fair Value
Price UK£33.51
AnalystConsensusTarget UK£44.18
Fair ValueUK£44.18
Share PriceUK£33.51
24.2% undervalued intrinsic discount
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 64 Fair Values set on narratives written by author
REL Community Narratives
AN
Fair Value UK£44.18 24.2% undervalued intrinsic discount
Analysts Highlight Mixed Outlook for RELX as Valuation and Profit Estimates Rise
1users have liked this narrative
0users have commented on this narrative
37users have followed this narrative
Analysts Highlight Mixed Outlook for RELX as Valuation and Profit Estimates Rise
Key Takeaways Accelerated shift to AI-powered digital products and data analytics is deepening customer value, spurring recurring revenue growth, and expanding profit margins. Focus on high-value digital subscriptions and prudent capital allocation strengthens long-term revenue momentum and supports sustainable EPS expansion.Read more
1users have liked this narrative
0users have commented on this narrative
37users have followed this narrative
AN
UK£44.18
24.2% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
6.42% p.a.
Profit Margin
23.42%
Future PE
35.7x
Share price in 2028
UK£54.53
Snowflake Analysis
RELX PLC Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- 1.06
- 65.48%
- 20.19%
- 339.2%
About REL
- Founded
- 1903
- Employees
- 36000
- CEO
- WebsiteView website
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides scientific and medical information and data sets that help researchers and healthcare professionals to advance science and health outcomes. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
